| WHAT: |
Experts from around the world will
gather at the University of
Pennsylvania School of Medicine for a special symposium to review
the most current research and explore the future of personalized
medicine.
Hosted by the Institute
for Translational Medicine and Therapeutics,
progress and perspectives of personalized medicine will be
presented by leaders in the field from the clinical, pharmaceutical,
and ethics arenas.
Reporters attending this conference can expect to hear about:
- Imaging techniques to track response to psychiatric and
neurological drugs.
- The hunt for genes that predispose us
to high blood pressure.
- Childhood leukemia as a model for
cancer pharmacogenomics.
For a full agenda and registration, please visit the ITMAT
website. |
| WHEN: |
Wednesday April, 25 8:00AM – 7:30 PM |
| WHERE: |
Biological Research Building Auditorium [map]
University of Pennsylvania School of Medicine
421 Curie Boulevard
Philadelphia PA 19104 |
Editor’s Note: Registration is not required if you
plan to only attend the Roundtable Session open to the public,
which begins at 6:15pm. For the Roundtable, please contact
Molly Reagan for more information:
Phone: 215-898-1188
Email: mreagan@mail.med.upenn.edu
###
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S. News
& World Report's most recent ranking of top research-oriented
medical schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its superior
education and training of the next generation of physician-scientists
and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals,
all of which have received numerous national patient-care honors [Hospital
of the University of Pennsylvania; Pennsylvania Hospital, the nation's
first hospital; and Penn Presbyterian Medical Center]; a faculty practice
plan; a primary-care provider network; two multispecialty satellite
facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.